KMS-20 Cell Line

Product Name	KMS-20 Cell Line
Cat.No	RWT-1245
Size	1*10^6 cells/vial
Description	KMS-20 is a human multiple myeloma cell line derived from plasma cell malignancy and widely used in multiple myeloma research. This suspension cell line exhibits stable growth characteristics and reproducible experimental performance, making it an ideal in vitro model for cancer biology studies, drug screening, and functional genomics research.
Tissue	Bone marrow
Species	Human
Gender	Famale, 65-Year-Old
Disease	Multiple Myeloma (MM)
Biosafety Level	BSL 1. Runtogen determines the biosafety level of a material based on our risk assessment as guided by the current edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL), U.S. Department of Health and Human Services.
Morphology	Lymphocyte-like, Suspension
Culture Method	RPMI1640 medium with 10% featal bovine serum+1% P/S.
Quality Control	KMS-20 Cell Line is negative for mycoplasma, bacteria, yeast, and fungi.
Shipping	Dry ice
Storage	Upon arrival, Check all containers for leakage or breakage. Remove the frozen cells from the dry ice packaging and immediately place the cells at a temperature below -130°C, preferably in liquid nitrogen vapor, until ready for use.
Warranty	Our KMS-20 Cell Line is warranted for 30 days from the date of shipment, provided that the customer has stored and handled the product according to the information included on the product datasheet, website, and COA.
Disclaimers	KMS-20 cell line is intended for laboratory research use only. It is not intended for any human or animal therapeutic use, any animal or human consumption, or any diagnostic use. Any proposed commercial use is prohibited without a license from Runtogen.

Online Inquiry

Online Inquiry